Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry
Journal of Scientific Innovation in Medicine · 2019
DOI: 10.29024/jsim.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Scientific Innovation in Medicine, 2019. Verfasst von Charles Gaulin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gaulin, C., & Osorio, G. (2019). Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry. Journal of Scientific Innovation in Medicine. https://doi.org/10.29024/jsim.11
Vancouver
Gaulin C, Osorio G. Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry. Journal of Scientific Innovation in Medicine. 2019. doi:10.29024/jsim.11
BibTeX
@article{Gaulin2019,
author = {Gaulin, Charles and Osorio, Georgina},
title = {Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry},
journal = {Journal of Scientific Innovation in Medicine},
year = {2019},
doi = {10.29024/jsim.11}
}
EUVIMED